EUVIMEDΑνακαλύψτε το EUVIMED
CrossrefΚάρτα πληροφοριών

Cellular and Histopathological Hallmarks of Acute and Chronic Rejection in Vascular Composite Allografts: A Systematic Review

Leonard Knoedler, Tobias Niederegger, Jakob Fenske, Murtaja Satea, Alessia Taggiasco, Guilherme F. Machado, Thomas Schaschinger, Romane Gaillard, Jadyn Heffern, Jasper Iske, Maximilian Richter, Max Heiland, Curtis L. Cetrulo, Haïzam Oubari, Alexandre G. Lellouch

Clinical Transplantation · 2026-11 · 40 (11)

DOI: 10.1111/ctr.70744 ↗
ΠερίληψηΒιβλιογραφικά στοιχεία

Περίληψη

ABSTRACT Background VCA provides major reconstructive benefits but is limited by frequent rejection. Given the high immunogenicity of skin and mucosa, this systematic review synthesizes the cellular, immunophenotypic, and histopathological features of acute rejection (AR) and chronic rejection (CR) across all VCA types to improve surveillance and long‐term graft outcomes. Methods RISMA‐compliant systematic review (PROSPERO CRD420251146481) of PubMed, Embase, and Cochrane identified original human VCA studies reporting histopathologic/immunologic findings in acute and/or chronic rejection. Data on rejection rates, immune cell profiles, and tissue injury patterns were extracted but heterogeneity precluded meta‐analysis; categorical comparisons used chi‐squared or Fisher's exact tests. Results Across 51 studies (2000–2025), 208 VCA rejection episodes were reported: AR 177 (85%) and CR 31 (15%), with distributions differing by VCA type ( p < 0.0001). AR was most common in FVCA 102 (58%) and UE VCA 48 (27%); CR in FVCA 19 (61%) and KVCA 7 (23%). AR was mainly T‐cell‐driven (CD8+ 49%, CD4+ 47%, CD3+ 35%), while CR was characterized by endothelial involvement/graft vasculopathy ( n = 10, 20%) and fibrosis ( n = 6, 12%). Histopathology was reported in 78% of studies, most often associated with cellular infiltrates 73%, perivascular lymphocytic infiltrates 71%, epidermal apoptosis/necrosis 49%, interface dermatitis 25% and C4d deposits 18%. Conclusions AR and CR in VCA have distinct, heterogeneous patterns that vary by graft type. Limited reported data, especially for CR, highlight the need for standardized criteria and multicenter longitudinal studies. Surveillance with integrated histomolecular profiling may enable earlier detection and more targeted immunomodulation to improve long‐term outcomes.

Γνώση που ταιριάζει στην εργασία σας.

Από το δωρεάν ξεκίνημα και την προσωπική βιβλιογραφική έρευνα έως το πλήρες Research Suite.

Προβολή τιμολογίων →

Περιλαμβάνονται όλα τα πλήρη κείμενα εκδοτών;

Όχι. Οι βιβλιογραφικές καταχωρίσεις, οι περιλήψεις και τα πλήρη κείμενα είναι διαφορετικά περιεχόμενα. Το αν είναι διαθέσιμο ένα πλήρες κείμενο εξαρτάται από την πηγή, το Open Access και τις υπάρχουσες άδειές σας. Ένα πακέτο EUVIMED δεν υποκαθιστά πρόσθετα δικαιώματα εκδοτών.

Προβολή τιμολογίων →